Fluorescence guided surgery (FGS) system is an imaging technique that allows the surgeon to visualize different structures and types of tissue during a surgical procedure that may not be as visible under white light conditions. It is a promising technology that could change the future of reconstructive and oncological procedures and potentially improve patients' outcomes. FGS is used to generate real-time fluorescence image of a surgical region and guide a surgery. Thus, FGS has been currently used for multiple surgical situations.

Market Dynamics:

Rise in demand for fluorescence guided surgery systems, increasing prevalence of cancer, rise in usage of advanced imaging techniques, increasing number of surgical procedures for target diseases, and increase in research and development are major factors expected to augment the growth of the global fluorescence guided surgery systems market.

In April 2022, Imperial College awarded Tate Group a grant for the development of fluorescent probes for the visualization of tumors during cancer surgery. This collaboration is enabling the development of cutting-edge real-time breast cancer imaging technology which is hoped to ultimately be used to increase the accuracy in surgical removal of breast tumors, and potentially other cancers too.

Moreover, in November 2020, OnLume Inc. has been awarded a substantial grant from the United States National Institutes of Health (NIH)’s National Cancer Institute (NCI) to advance development of its proprietary device for Fluorescence-Guided Surgery (FGS).

Key features of the study:

• This report provides in-depth analysis of the global fluorescence guided surgery systems market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global fluorescence guided surgery systems market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Karl Storz, PerkinElmer, Curadel LLC, OnLume Inc., Medtronic PLC, Hamamatsu Photonics KK, Stryker Corporation, Shimadzu Corporation, Gentige (Fluoptics), Irillic Pvt. Ltd., and Olympus Corporation (Quest Medical Imaging), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global fluorescence guided surgery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fluorescence guided surgery systems market.

Detailed Segmentation:

• Global Fluorescence Guided Surgery Systems Market, By Type:
• • SPY System
  • PDE System
  • VS3 Iridium System
  • Other Types
• Global Fluorescence Guided Surgery Systems Market, By Surgery:
• • Open Surgery
  • Laparoscopy/Endoscopy
• Global Fluorescence Guided Surgery Systems Market, By Application:
• • Cancer Surgeries
  • Cardiovascular Surgeries
  • Other Applications
• Global Fluorescence Guided Surgery Systems Market, By Geography:
• • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
• • Irillic Pvt. Ltd.
  • Karl Storz
  • PerkinElmer
  • Curadel LLC
  • Gentige (Fluoptics)
  • OnLume Inc.
  • Medtronic PLC
  • Hamamatsu Photonics KK
  • Stryker Corporation
  • Shimadzu Corporation
  • Olympus Corporation (Quest Medical Imaging)